CRL Charles River Laboratories International, Inc.
$288.50
Charles River Laboratories International, Inc. (CRL) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is $2.96 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +7.7% since its last earnings release on August 5, 2026.
Charles River Laboratories International Beat Consensus Estimates, Raises Guidance
Wednesday, August 5, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 6
Friday · 7:00 AM ET
Earnings Whisper
-
vs $2.96
Rev est $943.09M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$284.13
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Charles River Laboratories International, Inc.
Charles River Laboratories International Inc provides research models and services required to enable in vivo drug discovery and development.
Sector
Healthcare
Industry
Research Services